Sinopharm
1099.HK
#2229
Rank
โ‚น756.08 B
Marketcap
โ‚น242.28
Share price
-2.11%
Change (1 day)
21.45%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚น7.444 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.444 Trillion. In 2024 the company made a revenue of โ‚น7.444 Trillion a decrease over the revenue in the year 2023 that were of โ‚น7.844 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚น7.444 T-5.1%
2023โ‚น7.844 T5.42%
2022โ‚น7.440 T-2.1%
2021โ‚น7.600 T16.85%
2020โ‚น6.504 T14.95%
2019โ‚น5.658 T21.52%
2018โ‚น4.656 T5.93%
2017โ‚น4.395 T27.22%
2016โ‚น3.454 T5.37%
2015โ‚น3.278 T9.14%
2014โ‚น3.004 T17.22%
2013โ‚น2.562 T25.94%
2012โ‚น2.034 T34.61%
2011โ‚น1.511 T55.34%
2010โ‚น973.16 B35.79%
2009โ‚น716.67 B37.56%
2008โ‚น521.00 B31.43%
2007โ‚น396.42 B40.26%
2006โ‚น282.62 B